Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
editorial
. 1999 Nov;37(11):3783–3784. doi: 10.1128/jcm.37.11.3783-3784.1999

Further Evaluation of the MRSA-Screen Kit for Rapid Detection of Methicillin Resistance

Deborah J E Marriott 1,2, Thomas Karagiannis 1,2, John L Harkness 1,2, Phillip Kearney 1,2
PMCID: PMC85765  PMID: 10610377

We noted with interest the recent publication by Cavassini et al. (2) evaluating the MRSA-Screen, a latex agglutination kit detecting PBP 2a production by Staphylococcus aureus, thus allowing rapid detection of methicillin resistance. We have recently undertaken a similar study in a geographically distinct location (Sydney, Australia) and wish to share our findings.

A total of 159 clinically significant coagulase-positive and -negative staphylococcal isolates were collected between May and December 1998 from patients at St. Vincent's Hospital, Sydney, and an additional 24 isolates were kindly supplied by Tom Gottlieb, Microbiology Department, Concord Repatriation Hospital, Sydney. All organisms were tested for phenotypic methicillin resistance by a disc diffusion technique (modified Stokes method). The MRSA-Screen latex agglutination test (Denka-Seiken Pty Ltd) was performed according to the manufacturer's instructions. The mecA and 16S rRNA genes were detected by multiplex PCR using published methods (1) to confirm methicillin resistance in staphylococci. The MRSA-Screen and mecA gene detection were performed by investigators blinded to other results for each organism.

The results are summarized in Table 1. One hundred and twenty-one methicillin-resistant S. aureus (MRSA) isolates were confirmed by mecA gene detection and MRSA-Screen latex agglutination test. One phenotypic MRSA was repeatedly negative by mecA gene detection but positive by the MRSA-Screen. Of the 35 organisms reported by phenotypic testing as methicillin-sensitive S. aureus (MSSA), there were discordant results for four isolates. One organism was determined to be MSSA but was positive by the MRSA-Screen test and possessed a mecA gene. Two MSSA isolates demonstrated the mecA gene but were negative by the MRSA-Screen test, and another MSSA was positive by the MRSA-Screen but lacked the mecA gene.

TABLE 1.

Results for 183 staphylococcal isolates

Method No. of isolates identified as:
MRSA MSSA MRCNS MSCNS
Disc susceptibility testing 121 35 16 11
MRSA-Screen 121 2 13 0
mecA detection 120 3 16 0

The MRSA-Screen kit is not validated for coagulase-negative staphylococci (CNS), although the mechanism of methicillin resistance in the organisms is similar to that in S. aureus. In the original description of this test (3) the authors tested five methicillin-resistant CNS (MRCNS), and the MRSA-Screen was positive for each isolate. As CNS are increasingly important clinical isolates, we performed PCR for the mecA gene and the MRSA-Screen on 27 CNS. No methicillin-sensitive CNS (MSCNS) were positive by the MRSA-Screen test. However, 3 of 16 CNS which possessed the mecA gene were negative by the MRSA-Screen test.

Our results and those of Cavassini et al. suggest that the MRSA-Screen is a rapid and accurate method to detect methicillin resistance in staphylococci. However an abstract was recently published by Wallrauch and Braveny (4) in which they evaluated a latex agglutination test for the detection of PBP 2a (manufacturer not specified) against 38 MRSA isolates and 10 MRCNS. Despite prolonged observation (up to 10 min) 9 of 38 MRSA isolates and 10 of 10 MRCNS failed to agglutinate. The specificity was high (100%) but the sensitivity was only 47% after 3 min of observation, increasing to 76% at 10 min.

It is possible that we studied clonal isolates of MRSA which produced a PBP 2a that was readily detected by the MRSA-Screen. DNA fingerprinting is currently being undertaken on all isolates, but preliminary data suggests that the 121 MRSA isolates consisted of at least six different clones. In addition, Cavassini et al. studied isolates with 60 different pulsed-field gel electrophoresis patterns, suggesting that the MRSA-Screen kit is accurate over a wide range of MRSA clonal variants. An alternative explanation for the poor results of Wallrauch and Braceny may be difficulties with methodology. Positive and negative controls are not provided with the MRSA-Screen kit. We found it essential to include these from our stock isolates, as overreading weak agglutination by mecA gene-negative organisms may lead to false-positive results. In addition, one critical step is the extraction procedure in which boiling for 3 min is recommended. We noted that more reproducible results were obtained when a heating block was substituted for boiling. The heating time is critical for avoiding false-positive results associated with nonspecific agglutination from underheating or false-negative results from overheating.

One important feature of the MRSA-Screen is the rapid turnaround time, which reduced the detection time for methicillin-resistant isolates in our laboratory from 48 to 72 h to approximately 26 h. The test takes approximately 20 min, and organisms can be batched to further reduce the workload.

In summary, we found the MRSA-Screen latex agglutination test to be a simple, rapid, and accurate test to determine methicillin resistance in S. aureus isolates. No false-negative results were noted for isolates which phenotypically expressed methicillin resistance, although two S. aureus isolates possessed the mecA gene but were negative by the MRSA-Screen and methicillin sensitive by phenotypic testing, suggesting repression of the mecA gene and, therefore, the PBP 2a gene product. There was only one false-positive result for an isolate which was negative for the mecA gene and phenotypically methicillin sensitive. The results for CNS suggest that although the MRSA-Screen is not validated for these organisms it is a useful screening test. Further work is needed to confirm this.

REFERENCES

  • 1.Bignardi G E, Woodford N, Chapman A, Johnson A P, Speller D C E. Detection of the mecA gene and phenotypic detection of resistance in Staphylococcus aureusisolates with borderline or low level methicillin resistance. J Antimicrobiol Chemother. 1996;37:53–63. doi: 10.1093/jac/37.1.53. [DOI] [PubMed] [Google Scholar]
  • 2.Cavassini M, Wenger A, Jaton K, Blanc D S, Bille J. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol. 1999;37:1591–1594. doi: 10.1128/jcm.37.5.1591-1594.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nakatomi Y, Sugiyama J. A rapid latex agglutination assay for the detection of penicillin-binding protein 2′. Microbiol Immunol. 1998;42:739–743. doi: 10.1111/j.1348-0421.1998.tb02347.x. [DOI] [PubMed] [Google Scholar]
  • 4.Wallrauch C, Braveny I. Ninth Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. 1999. Evaluation of a latex agglutination test to screen for methicillin resistant Staphylococcus aureus, abstr. M30. [Google Scholar]
J Clin Microbiol. 1999 Nov;37(11):3783–3784.

AUTHORS' REPLY

M Cavassini 1,2, A Wenger 1,2, K Jaton 1,2, J Bille 1,2, D S Blanc 1,2

The letter of Marriott et al. is interesting and presents new data on the performance of the recently released latex agglutination test designed to rapidly detect the PBP 2a linked to methicillin resistance in S. aureus. These authors obtained sensitivity and specificity values (100 and 94%, respectively, according to their definition of methicillin resistance) similar to ours, using a collection of 156 S. aureus clinical isolates from Australia. While confirming the usefulness of this test, they made two interesting observations. The first one relies on the necessity of strictly respecting the recommended procedure (inoculum, boiling temperature and duration, reading time of the agglutination) and of adding positive and negative control strains not provided by the manufacturer. When complying with these technical points, one can also obtain the same excellent sensitivity and specificity at the bench during normal daily activity. After the completion of our study (1-1) we have introduced this test in our routine work, where we encounter methicillin resistance in about 2% of our S. aureus clinical isolates. Rather than doing an MRSA-Screen test for all S. aureus isolates, we restrict its use to the strains presenting resistance to several antibiotics and/or reduced susceptibility to ceftriaxone (diameter of zone of inhibition ≤20 mm) by the National Committee for Clinical Laboratory Standards recommended disk diffusion test.

Out of a total of 154 fresh clinical isolates tested, the concordance between MRSA-Screen test and PCR results for the mecA gene reached 99.4% (31 isolates positive by both methods, 122 isolates negative by both methods, and 1 isolate MRSA-Screen negative and PCR-positive for the mecA gene).

The second interesting comment of Marriott et al. concerns the performance of the test with CNS. It is important to mention first that this test has not been designed or validated for species of staphylococci other than S. aureus. However, because of the analogy of the mechanisms of resistance to methicillin in S. aureus and in CNS, we tested it, as did the Australian authors, against a series of 48 clinically significant CNS isolates belonging to various species. Our results differed somewhat from those obtained by Marriott et al. Out of 26 mecA gene-positive CNS isolates, between 13 and 23 were positive by the MRSA-Screen test when tested on three separate occasions (giving a sensitivity varying from 50 to 88%). In contrast to MRSA isolates, the agglutination reaction was often weak and poorly reproducible with CNS but was generally more pronounced when the time of mixing before reading was prolonged to 10 to 15 min. The specificity was also lower (59 to 86%) for MRCNS than for MRSA, mainly due to many false, weakly positive agglutination reactions. Thus, albeit the reason is not straightforward, this test should not be used to determine the resistance to methicillin in organisms other than S. aureus.

Two articles on this test have recently been published (1-2, 1-3).

REFERENCE

  • 1-1.Cavassini M, Wenger A, Jaton K, Blanc D S, Bille J. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol. 1999;37:1591–1594. doi: 10.1128/jcm.37.5.1591-1594.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 1-2.van Leeuwen W B, van Pelt C, Luijendijk A, Verbrugh H A, Goessens W H F. Rapid detection of methicillin resistance in Staphylococcus aureusisolates by the MRSA-Screen latex agglutination test. J Clin Microbiol. 1999;37:3029–3030. doi: 10.1128/jcm.37.9.3029-3030.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 1-3.van Griethuysen A, Pouw M, van Leeuwen N, Heck M, Willemse P, Buiting A, Kluytmans J. Rapid slide latex agglutination test for detection of methicillin resistance in Staphylococcus aureus. J Clin MIcrobiol. 1999;37:2789–2792. doi: 10.1128/jcm.37.9.2789-2792.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES